2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society

Miki Fujimura; Teiji Tominaga; Satoshi Kuroda; JUN C. TAKAHASHI; Hidenori Endo; Kuniaki Ogasawara; Susumu Miyamoto

doi:10.2176/jns-nmc.2021-0382

February 21, 2022Neurologia medico-chirurgicaOpen Access

2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society

View Full Paper

Ask AI

Bookmark

Share

Key Points

To establish evidence-based clinical recommendations for the surgical and postoperative management of patients diagnosed with moyamoya disease.
Expert consensus and evidence appraisal conducted by the Research Committee on Moyamoya Disease and the Japan Stroke Society.
Formulation of clinical recommendations graded by strength and level of supporting evidence.
Surgical revascularization is recommended for patients with moyamoya disease presenting with cerebral ischemic symptoms to decrease transient ischemic attack frequency and stroke risk (Recommendation Grade B, Level of Evidence: low).
Appropriate blood pressure control is deemed reasonable to manage postoperative cerebral hyperperfusion syndrome while avoiding secondary cerebral ischemia (Recommendation Grade C, Level of Evidence: low).

Implication

Clinical practice guidelines recommend surgical revascularization for ischemic moyamoya disease, highlighting improved symptom control through careful blood pressure regulation.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Fujimura et al. (2022) studied this question.

synapsesocial.com/papers/6ab32c9be7f4978bdcc8e817 https://doi.org/10.2176/jns-nmc.2021-0382

View Full Paper

Ask AI

Bookmark

Share

2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society

Key Points

Implication

Abstract

Discussion

Cite This Study

2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading